Public Article
-
verified
Neovascular Glaucoma – A Review
ISSN: 2687 - 5365Publisher: author   
Neovascular Glaucoma – A Review
Indexed in
Medical Sciences
ARTICLE-FACTOR
1.3
Article Basics Score: 3
Article Transparency Score: 2
Article Operation Score: 3
Article Articles Score: 3
Article Accessibility Score: 2
SUBMIT PAPER ASK QUESTION
International Category Code (ICC):
ICC-1702
Publisher: International Journal Of Academic Medicine And Pharmacy Ne..
International Journal Address (IAA):
IAA.ZONE/268771265365
eISSN
:
2687 - 5365
VALID
ISSN Validator
Abstract
Neovascular glaucoma (NVG) is a severely blinding disease with high intraocular pressure (IOP) resistant to treatment. The main problem in NVG is the release of vascular endothelial growth factor (VEGF) due to retinal ischemia caused by the underlying disease. Both the underlying disease and intraocular pressure should be treated in management of patients with NVG. The purpose of this review is to discuss etiology, pathogenesis, clinic classification and management of NVG. The main purpose in NVG management is to prevent the development of NVG by treating the underlying cause mainly proliferative diabetic retinopathy (PDR), central retinal vein occlusion (CRVO) and ocular ischemic syndrome (OIS). If NVG has developed, then it will be necessary to both treat the underlying etiology and high intraocular pressure. Panretinal photocoagulation (PRP) and anti-VEGF drugs are important in the treatment of NVG. Anti-glaucomatous drugs that red...